On Wednesday, Shares of Merck & Co., Inc. (NYSE:MRK), added 6.07% and closed at $64.18 in the last trading session. The last trading range of the stock ranges between $62.76 and $65.00. The company’s Market capitalization is $178.31 Billion with the total Outstanding Shares of 2.76 billion. Merck (MRK), known as MSD outside the United States and Canada, recently declared that new data investigating the use of KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, in patients with formerly treated advanced urothelial cancer will be presented at the Society for Immunotherapy of Cancer’s (SITC) 31st Annual Meeting, Nov. 9-13. Data on overall survival (OS) and progression-free survival (PFS) from the phase 3 KEYNOTE-045 study – investigating KEYTRUDA contrast to investigator’s choice chemotherapy in patients with metastatic or locally advanced or unresectable urothelial cancer that has recurred or progressed following platinum-based chemotherapy – will be presented for the first time; these data were accepted as a late-breaking abstract. In addition, results from three different studies exploring the utility of various biomarkers for KEYTRUDA will be presented at the meeting.
Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $47.94 and reached to max level of $65.00. The EPS of company is strolling at 1.97.
Shares of Cognizant Technology Solutions Corp (NASDAQ:CTSH), dropped -3.43% and closed at $53.01 in the last trading session. The last trading range of the stock ranges between $51.46 and $53.19. The company’s Market capitalization is $32.24 Billion with the total Outstanding Shares of 606.70 million. Cognizant Technology Solutions Corporation provides information technology (IT), consulting, and business process services worldwide. The company operates through four segments: Financial Services, Healthcare, Manufacturing/Retail/Logistics, and Other. Its consulting and technology services include IT strategy consulting, program administration consulting, operations improvement consulting, strategy consulting, and business consulting services; and application design and development, systems integration, enterprise resource planning, and customer relationship administration implementation services. The company also offers enterprise information administration services, such as planned, advisory, and administration consulting; enterprise data administration; descriptive analytics/business intelligence; planned corporate performance administration; and packaged analytics services, in addition to big data services that assist clients in managing and deriving actionable insights. In addition, it provides application testing services; and develops, licenses, implements, and supports proprietary and third-party software products, in addition to offers digital technologies services. Further, the company offers outsourcing services, such as application maintenance services; IT infrastructure services; and business process services, counting clinical data administration, pharmacovigilance, equity research support, commercial operations, and order administration. It serves various industries, counting banking and insurance; healthcare and life sciences; manufacturing and logistics; retail, travel, and hospitality; consumer goods; communications; information, media, and entertainment; and technology.
Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $45.44 and reached to max level of $68.98. The EPS of company is strolling at 2.56.